Beta's eVTOL, Ava, combines the flight characteristics of a helicopter, drone and fixed-wing airplane with cockpit and control systems that revolutionize the pilot's interface. Beta has partnered with, and is funded by, United Therapeutics biotechnology company. The eVTOL is ultimately designed to carry organs from a manufacturing facility to hospitals.
Stage of Development
Company Name: Beta Technologies
Headquarters: Burlington, Vermont
Beta CEO: Kyle Clark
Product Name: Ava (prototype)
Type of Machine: Winged eVTOL Aircaft
Power: All-electric. Beta is also creating a recharging dock for the Ava – a landing pad that will recharge the aircraft.
Capacity: Ultimately designed for cargo - specifically, organ transport.
Wingspan: 34 feet
Vertical take-off and landing: 4 pairs of counter-rotating rotors. A flight controller distributes electric propulsion power based on position and direction of each rotor.
Fixed wing flight: rotors rotate forward (perpendicular to ground) and power consumption drastically decreases.
Range: 150 miles.
Speed: 170 mph.
Funding: Backed by biotechnology company, United Therapeutics.
Our Take on Beta
Beta Technologies is strategically located in Burlington, VT for easier access to the state's congressional delegation, the airport's leadership and, by extension, its Federal Aviation Administration staff - the company currently occupies a Horizon Air hangar at Burlington International Airport. While regulatory and certification hurdles are ahead for Beta's Ava, the relationships they have built will help them navigate that process. Beta has made over 170 test flights in 2018, and was able to go from an initial concept to "wheels off the ground" in just 10 months, an impressive feat.
The Latest News from TransportUP
The Airbus Altiscope BlueprintFebruary 14, 2019
Hoversurf’s New Video BlogFebruary 13, 2019
Frankfurt Airport Makes Air Taxi Integration PlansFebruary 12, 2019
Urban Air Mobility – The Quest for the Right Shape*February 11, 2019
Back to The Hangar